Atypical functions of xenobiotic receptors in lipid and glucose metabolism
Related Experiment Video
Updated: Aug 10, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Jingyuan Wang1, Peipei Lu1, Wen Xie1,2
1Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract:
Xenobiotic receptors are traditionally defined as xenobiotic chemical-sensing receptors, the activation of which transcriptionally regulates the expression of enzymes and transporters involved in the metabolism and disposition of xenobiotics. Emerging evidence suggests that "xenobiotic receptors" also have diverse endobiotic functions, including their effects on lipid metabolism and energy metabolism. Dyslipidemia is a major risk factor for cardiovascular disease, diabetes, obesity, metabolic syndrome, stroke, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Understanding the molecular mechanism by which transcriptional factors, including the xenobiotic receptors, regulate lipid homeostasis will help to develop preventive and therapeutic approaches. This review describes recent advances in our understanding the atypical roles of three xenobiotic receptors: aryl hydrocarbon receptor (AhR), pregnane X receptor (PXR), and constitutive androstane receptor (CAR), in metabolic disorders, with a particular focus on their effects on lipid and glucose metabolism. Collectively, the literatures suggest the potential values of AhR, PXR and CAR as therapeutic targets for the treatment of NAFLD, NASH, obesity and diabetes, and cardiovascular diseases.
Insights
Xenobiotic receptors like AhR, PXR, and CAR have unexpected roles in regulating lipid and energy metabolism. Targeting these receptors may offer new treatments for metabolic disorders such as NAFLD, obesity, and cardiovascular disease.
Area of Science:
- Metabolic biochemistry
- Molecular endocrinology
- Pharmacology
Background:
- Xenobiotic receptors traditionally mediate xenobiotic metabolism and disposition.
- Emerging evidence highlights their significant roles in endobiotic functions, including lipid and energy homeostasis.
- Dyslipidemia, linked to metabolic disorders, necessitates understanding regulatory mechanisms.
Purpose of the Study:
- To review recent advances in understanding the atypical roles of xenobiotic receptors in metabolic disorders.
- To focus on the effects of aryl hydrocarbon receptor (AhR), pregnane X receptor (PXR), and constitutive androstane receptor (CAR) on lipid and glucose metabolism.
- To explore their potential as therapeutic targets for metabolic diseases.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of studies investigating xenobiotic receptors in metabolic regulation.
- Synthesis of findings on the impact of AhR, PXR, and CAR on lipid and glucose homeostasis.
Main Results:
- Xenobiotic receptors (AhR, PXR, CAR) exhibit significant endobiotic functions impacting metabolic pathways.
- These receptors influence lipid and glucose metabolism, contributing to or mitigating metabolic disorders.
- Dysregulation of these receptors is implicated in conditions like NAFLD, NASH, obesity, and cardiovascular disease.
Conclusions:
- AhR, PXR, and CAR play crucial, albeit atypical, roles in maintaining metabolic homeostasis.
- Targeting AhR, PXR, and CAR presents a promising therapeutic strategy for metabolic disorders.
- Further research into these receptors could lead to novel treatments for NAFLD, NASH, obesity, diabetes, and cardiovascular diseases.
More Related Videos
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Insulin: The Receptor and Signaling Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

